Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Its short sell,they borrow your shares, sell them in the open market. When the price drop, they buy them back and return the shares. They (short seller) profit the difference.
Read some where that if you have a sale order, your shares cannot be borrowed or they are forced to sell. Gonna try to put a limit order as high as I can
Woot woot :)
I agree with most of what you said. But patent approval does not mean anything. Licensing would generate revenue and hence the SP appreciation.
Listing to Nasdaq requires some financial proof that IMLFF has solid revenue or pretax earning. Look at on P6 and it will tell you the route it could go for. No way that we could get uplisted in 2018. IF they do, I would be the first cheering for it
Sometime when you buy a company, you are not just buying a company. You are buying their distribution network and the customer.
In case of NXTTF, I got a feeling they are more likely become a potential take over target as they span across continent.
Got in at 0.245. A bit pricey compared to last week. But long term I should be ok.. Lets go!!!
The other part of going to Nasdaq is that Inmed needs to be in positive. If I am not mistaken, it has to be 2 yrs..so we are that far away. Thats assuming we are going Nasdaq
Is auditor getting hired? Was it per request from Inmed? If so, that could be a good sign as lots of companies do have gheir financial audited prior to uplisting
Its alright. Today you win and laugh w the victory lap. Thats all that matters for now. Bye:)
Lol. Thats all you can do huh:)
Should not be giving advice if you cant walk the talk
So much anger
Flair09..email me at hoidfw@gmail.com and let me know that it is you. I used the email for my junk emails, so let me know its you. Have a stock for you to look at that may be interest of you
Thanks:)
Had/ have high hope for this one. I guess I just have to wait a bit longer for this to materialize. I agree number is there and from that perspective, there is no issue in uplisting other than the SP.
Bought more at .4975. Feel crazy right now with my decision. But I have a pretty good feeling we are gonna be ok :)
These are just speculations on your part.
Lets GO!!!!!
The potential of just supplying players in industry alone is massive..not just pharma companies.
Best situation is for this to stay independent. You will see much bigger appreciation assuming mgmt keeps executing as they should
I am a bit pissed thar Ameritrade holds my fund. Transferred ACH on Friday and been trying to buy since yesterday..everytime it said I dont have fund. Called them and was informed that the money would be available Thu.
So now I am on the same boat. To buy or not to buy. Keep reminding myself tof what you said. That this may go back lower (may be)..well time will tell LOL
How far do you think we will go up with that number?
GW, I was hoping to get in yesterday - but my fund did not clear. Apologize for my silly question..Do you think there is a good chance that this would come back down to $.15? I know a lot of ppl would say - what difference does it make long term..Personally buying at the right time would make a lot of difference in terms of number of shares when this hits $10, $20, $30 and so on.
Thanks for your input.
Anyone venture to make a guess where we will be price wise in Dec 2019 and Dec 2020?
Thank you Greenwillow for introducing me to this. Still doing some reading but sounds like a very terrific potential
Have my sell order at $3.75:)
Good point:)
Personally I prefer that Inmed stays independent and perhaps go through partnership instead.. That would be better for us I would think
Whats your exit strategy
Flair, are you buying more? Part of me wants to buy more but I have been hesitant as I had been burned in the past. Sometimes things that are too good to be true turn out to be the case.
That was so reckless of them to make such a claim. Obviously FDA cannot allow that as it requires scientific study or CT
This was actually my concerns..if those drugs are approved..then it is likely that plus cbd oil can no longer be marketed and sold..would that be a correct statement?
Anyone has link(s) to Gras certification? Cant seem to find the application on FDA site
In the warning letters, the FDA denied the companies’ claims that the products can be classified as dietary supplements, citing the Investigational New Drug Applications submitted for CBD-containing pharmaceutical drug candidates Sativex and Epidiolex.
Sounds like they likely consider this as active ingredients?
Thanks Flair and Greenwillow for reccomendations. I did open TD Ameritrade earlier today
Buying more when I have more opportunity/ fund. Lol
Scottrade is expensive for stocks lower than $1..they charge a flat fee plus percentage points.
Does anyone know that some brockerage firm does not allow trading in Marijuana stocks? I set up Wells Fargo Brockerage acc and tried to buy IMLFF and I was not able to do it..Called them and they told me that I could buy any otc or pink stocks..but not anything related to marijuana.